|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 55.92 USD | +0.22% |
|
+0.79% | +24.46% |
| Apr. 12 | Zacks Investment Research Downgrades Catalent to Underperform From Neutral, Price Target is $48 | MT |
| Apr. 08 | Sector Update: Health Care Stocks Decline Late Afternoon | MT |
Catalent, Inc. provided earning guidance for 2022. The company now expect revenue growth in the 19% to 22% range.
| 1st Jan change | Capi. | |
|---|---|---|
| +24.46% | 10.1B | |
| +25.83% | 653B | |
| +27.00% | 556B | |
| -6.76% | 354B | |
| +20.34% | 331B | |
| +3.00% | 296B | |
| +13.09% | 233B | |
| +5.46% | 201B | |
| -9.61% | 193B | |
| -6.26% | 144B |
CATALENT, INC. 
